Waldencast PLC (NASDAQ:WALD - Get Free Report) saw a large growth in short interest in the month of May. As of May 31st, there was short interest totalling 402,600 shares, a growth of 26.2% from the May 15th total of 318,900 shares. Based on an average daily volume of 96,300 shares, the days-to-cover ratio is currently 4.2 days. Approximately 3.4% of the company's shares are sold short.
Hedge Funds Weigh In On Waldencast
A number of institutional investors have recently modified their holdings of WALD. Charles Schwab Investment Management Inc. increased its position in shares of Waldencast by 16.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 64,895 shares of the company's stock worth $261,000 after acquiring an additional 9,130 shares during the period. JPMorgan Chase & Co. increased its position in shares of Waldencast by 116.3% during the fourth quarter. JPMorgan Chase & Co. now owns 93,561 shares of the company's stock worth $376,000 after acquiring an additional 50,311 shares during the period. Wells Fargo & Company MN increased its position in shares of Waldencast by 29.9% during the fourth quarter. Wells Fargo & Company MN now owns 14,571 shares of the company's stock worth $59,000 after acquiring an additional 3,358 shares during the period. Renaissance Technologies LLC increased its holdings in Waldencast by 10.3% during the fourth quarter. Renaissance Technologies LLC now owns 91,800 shares of the company's stock valued at $369,000 after buying an additional 8,600 shares during the period. Finally, Amitell Capital Pte Ltd purchased a new position in Waldencast during the fourth quarter valued at approximately $780,000. 41.97% of the stock is owned by hedge funds and other institutional investors.
Waldencast Stock Performance
Shares of NASDAQ:WALD remained flat at $2.25 during trading on Friday. 137,972 shares of the stock were exchanged, compared to its average volume of 131,600. The business's 50-day simple moving average is $2.52 and its two-hundred day simple moving average is $3.00. Waldencast has a fifty-two week low of $1.98 and a fifty-two week high of $4.74. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.66 and a current ratio of 1.35.
Analysts Set New Price Targets
A number of research firms recently weighed in on WALD. Wall Street Zen lowered shares of Waldencast from a "hold" rating to a "sell" rating in a research report on Thursday, May 22nd. Telsey Advisory Group reduced their price objective on shares of Waldencast from $5.00 to $4.00 and set an "outperform" rating on the stock in a research report on Thursday, May 15th. DA Davidson reissued a "buy" rating and issued a $7.50 price objective on shares of Waldencast in a research report on Wednesday, March 19th. Canaccord Genuity Group reduced their price objective on shares of Waldencast from $6.00 to $5.00 and set a "buy" rating on the stock in a research report on Thursday, May 15th. Finally, Alliance Global Partners reissued a "buy" rating on shares of Waldencast in a research report on Thursday, May 15th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $5.11.
Check Out Our Latest Stock Report on WALD
About Waldencast
(
Get Free Report)
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
See Also
Before you consider Waldencast, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waldencast wasn't on the list.
While Waldencast currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.